Abstract. Diminished ovarian reserve (DOR) refers to the decreased production of mature ova in ovarium and decreased quality of oocyte, leading to deficiency of the female sex hormone and decreased fertility. DOR can also develop into premature ovarian failure, which affects female life quality and constitutes an important cause of female infertility. A fast lifestyle, environmental deterioration and accumulated understanding of this disease, have led to an increase in the incidence of DOR. Therefore, reasonable and effective treatment for DOR is particularly important to improve ovarian function and female life quality as well as reduce infertility. This mini review provides recent updates regarding DOR and a summary of advancements in the treatment of DOR using Chinese and Western Medicine.
Introduction
Diminshed ovarian reserve (DOR) is a condition in which women between the ages of 16 and 40 experience impaired ovarian function, whereby the ovarian reserve is decreased or the quality of oocyte is reduced (1) . Clinical manifestations of DOR patients include oligomenorrhea, hypomenorrhea, amenorrhea and infertility (1) . In most cases, DOR is accompanied by soreness and weakness of waist and knees, hot flashes and sweating, insomnia and distraction (2) . DOR is not identified in traditional Chinese medicine (TCM), but is classified as a symptom of delayed menorrhea, oligomenorrhea, amenorrhea, irregular menstrual cycle and infertility (3) . Currently, there are many therapies for DOR. TCM treatment for DOR includes syndrome differentiation, specific prescriptions and medications, as well as TCM periodic therapy and acupuncture therapy (4) . Western medicine primarily utilizes hormone replacement therapy (HRT), oral contraceptives (OCP), dehydroepiandrosterone (DHEA), ovulation induction therapy, and assisted reproductive technique (ART) (4) .
The present study reviewed advancements in the treatment of DOR by TCM and Western medicine, and provided scientific evidence for the study and treatment of DOR.
Traditional Chinese medicine treatment
TCM treatment based on syndrome differentiation. Xu and Tan (1) studied TCM treatment of DOR based on syndrome differentiation, which included nephrasthenia syndrome, Guishao and Dihuang decoction, blood-stasis syndrome, Xuefu Zhuyu decoction, syndrome of upper hyperactivity of liver yang, Tianma Gouteng drink, cardiac and renal failure, Qing Xin Zi Shen decoction, syndrome of yang deficiency of spleen and kidney, and Jian Gu decoction. Hang (5) used treatment based on syndrome differentiation with Yu Lin Fang plus or minus nourishing blood and replenishing essence, reinforcing kidney and Tiao Chong (5) . In patients with stagnation of QI due to liver depression, identification of smooth liver, and regulation of QI and menstruation is important. In patients with stagnation of blood stasis, the blood circulation is promoted to remove meridian obstruction and eliminate stasis syndrome (5) . Dampness in the lungs leading to phlegm in patients should be eliminated, cold-dampness should be warming Yang to dispel the cold in order to dissipate the cold and remove the dampness, thereby clear away heat and toxic material for damp heat patients (5) . These forms of treatment were of good efficacy and worthy of clinical application. Li (6) studied the application of clinical TCM treatment for delayed menorrhea (DOR) including blood deficiency syndrome involving invigorating kidney and boosting essence, nourishing blood and the promotion of blood circulation; kidney deficiency and liver stagnation syndrome, invigorating kidney and the promotion of blood circulation, soothing the liver and 
Western medicine treatment
Hormone replacement therapy. HRT is the most commonly used therapy for DOR. Li and Chen (15) treated 78 DOR patients with sequential estrogen and progestogen therapy. After three courses of treatment, the baseline levels of FSH, LH and the FSH/LH ratio were significantly decreased (P<0.05), and the ovulation rate was significantly increased (P<0.05). However, the relative contraindications and side reactions limited the clinical applications of HRT, increasing the incidence of endometrial cancer, breast cancer and cardiovascular diseases.
Oral contraceptives. OCP such as desogestrel and ethinylestradiol (Marvelon) inhibit the hypo thalamic-pituitary-ovarian axis in a feedback manner, decrease the levels of FSH and E2, improve ovarian function and increase pregnancy rate. Pretreatment with OCP prior to ovulation induction may regulate the menstrual cycle in the patients with decreased ovarian function, increase synchronicity of follicular development, decrease cycle cancellation rate and obtained better ovulation induction. However, pretreatment with OCP may inhibit the increase of early endogenous FSH, gradual follicular development, prolonging the time of medication (16) . However, a large number of studies are required to evaluate the impact of OCP on DOR.
Dehydroepiandrosterone. Previous findings identified that androgen was able to increase follicular sensitivity to FSH through action on the androgen receptor (17) . DHEA was an androgen secreted by adrenal glands, the central nervous system and ovarian theca cells. Zhang (18) evaluated the effect of DHEA on the ovarian function of DOR patients and main adverse reactions of DHEA. Three months after DHEA treatment (50 mg/day), the serum level of FSH was decreased, the AMH level was increased, the antral follicle count was increased and the ovarian reserve was improved. However, the clinical efficacy of DHEA remains to be clarified.
Ovulation induction therapy.
A number of ovulation induction therapies are available for DOR patients, including induced ovulation and superovulation. Induced ovulation is regarded as the induction of ≥1 follicular growth by drugs or surgery in rare-ovulation or anovulation patients (19) . Superovulation is known as controlled ovarian hyper (COH) stimulation, is utilized in the controlled induction of multiple follicular development and maturation in in vitro fertilization (IVF) (20) . Commonly used ovulation induction therapies included long-term gonadotropin-releasing hormone agonist (GnRH-A) therapy, short-term GnRH-A therapy, antagonists therapy and microstimulation. It was reported that microstimulation achieved improved clinical outcome in the patients with poor ovarian reserve (21) .
Assisted reproductive technique. Assisted reproductive technique (ART) successfully resolved fertility issues in many women and has been extensively used in the treatment of infertility, especially IVF-embryo transfer (ET) (21) . Obtaining multiple quality eggs and sufficient quality embryos by COH was critical for successful IVF-ET. Geng et al examined different forms of stimulatation of ovulation solution in 87 patients who underwent IVF -ET owing to ovarian low reactivity. The microstimulation was found to have a higher cost-benefit ratio, and was deemed significant and applicable in the patients with ovarian low reactivity (22) .
Ovum donation. Ovum donation is a new technology in the treatment of infertility and may be useful to DOR patients. However, the clinical application of ovum donation has been limited owing to ethical, moral, and legal issues (23) .
Ovarian transplantation. Ovarian transplantation may recover the endocrine and reproductive function of DOR patients. Along with the development of animal-and human-assisted reproductive technology, particularly ovarian cryopreservation, oocyte in vitro maturation and fertilization have led to the improvement of the technology, technology combined with ovarian transplantation is considered a breakthrough, and is rapidly leading to the preservation and perpetuation of an important technology for female reproductive ability (24) . The development of ovarian transplantation, ovary autologous orthotopic or heterotopic transplantation, and ovarian xenograft have led to clinical application. However, various problems for ovarian transplantation, such as ischemia, injury of transplanted ovary by cryopreservation and immunological rejection have been previously identified.
Integrative medicine
Zhang et al (25) TCM is unique to improvement of ovarian reserve and increasing the ovarian responsiveness to gonadotrophin and ovarian sex hormone level due to the multi-system and multi-step regulatory functions. In addition, TCM has few side effects, and extensive clinical applications, although medication time and efficacy are gradual. The long-term efficacy of Western medicine in the treatment of DOR is unsatisfactory, with many contraindications and adverse reactions. The treatment of DOR with integrative medicine achieved good clinical efficacy. However, there were no uniform diagnostic criteria, therapeutic regime and evaluation criteria for DOR. Therefore, further investigation is required to develop a safe and efficacious therapy to improve ovarian reserve, prevent POF and treat infertility with DOR.
